Search research articles
Contact Us
Filters
Showing results (101-110 of 273) with videos related to
Page
of 28
Sort By:
Breast Cancer Research and Treatment
|
April 2, 2011
Monitoring of neoadjuvant chemotherapy using multiparametric, ²³Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer
Michael A Jacobs, Ronald Ouwerkerk, Antonio C Wolff, et al.
Journal of the National Cancer Institute. Monographs
|
June 12, 2015
Multiparametric and Multimodality Functional Radiological Imaging for Breast Cancer Diagnosis and Early Treatment Response Assessment
Michael A Jacobs, Antonio C Wolff, Katarzyna J Macura, et al.
American Journal of Clinical Pathology
|
April 29, 2016
A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma
Ashley Cimino-Mathews, Sangita Verma, Maria Cristina Figueroa-Magalhaes, et al.
Lancet (London, England)
|
November 11, 2022
Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial
Amanda Vrselja, Ardian Latifi, Rodney J Baber, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
March 10, 2017
The relationship of single-strand breaks in DNA to breast cancer risk and to tissue concentrations of oestrogens
Mathavi Sahadevan, Oukseub Lee, Miguel Muzzio, et al.
Pharmacogenetics and Genomics
|
February 15, 2024
Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptoms
Yuqing Liang, Christina L Gersch, Jennifer Lehman, et al.
Obesity (Silver Spring, Md.)
|
December 15, 2025
The Impact of Baseline Sleep as a Potential Moderator of Weight Loss Intervention in Breast Cancer Survivors: Results From the POWER-Remote Trial
Jennifer Y Sheng, Ruizhe Chen, Gary L Rosner, et al.
Breast Cancer Research and Treatment
|
March 13, 2020
Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period
Ciara C O'Sullivan, Sheeba Irshad, Zheyu Wang, et al.
JCO Oncology Practice
|
February 17, 2021
Developing Workshops to Enhance Hope Among Patients With Metastatic Breast Cancer and Oncologists: A Pilot Study
Mirat Shah, Anna Ferguson, Phyllis Dvora Corn, et al.
Journal of the National Cancer Institute
|
December 5, 2003
Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine
Vered Stearns, Michael D Johnson, James M Rae, et al.
Page
of 28
Search research articles
Search
Showing results (101-110 of 273) with videos related to
Sort By:
Page
of 28
Breast Cancer Research and Treatment
|
April 2, 2011
Monitoring of neoadjuvant chemotherapy using multiparametric, ²³Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer
Michael A Jacobs, Ronald Ouwerkerk, Antonio C Wolff, et al.
Journal of the National Cancer Institute. Monographs
|
June 12, 2015
Multiparametric and Multimodality Functional Radiological Imaging for Breast Cancer Diagnosis and Early Treatment Response Assessment
Michael A Jacobs, Antonio C Wolff, Katarzyna J Macura, et al.
American Journal of Clinical Pathology
|
April 29, 2016
A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma
Ashley Cimino-Mathews, Sangita Verma, Maria Cristina Figueroa-Magalhaes, et al.
Lancet (London, England)
|
November 11, 2022
Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial
Amanda Vrselja, Ardian Latifi, Rodney J Baber, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
March 10, 2017
The relationship of single-strand breaks in DNA to breast cancer risk and to tissue concentrations of oestrogens
Mathavi Sahadevan, Oukseub Lee, Miguel Muzzio, et al.
Pharmacogenetics and Genomics
|
February 15, 2024
Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptoms
Yuqing Liang, Christina L Gersch, Jennifer Lehman, et al.
Obesity (Silver Spring, Md.)
|
December 15, 2025
The Impact of Baseline Sleep as a Potential Moderator of Weight Loss Intervention in Breast Cancer Survivors: Results From the POWER-Remote Trial
Jennifer Y Sheng, Ruizhe Chen, Gary L Rosner, et al.
Breast Cancer Research and Treatment
|
March 13, 2020
Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period
Ciara C O'Sullivan, Sheeba Irshad, Zheyu Wang, et al.
JCO Oncology Practice
|
February 17, 2021
Developing Workshops to Enhance Hope Among Patients With Metastatic Breast Cancer and Oncologists: A Pilot Study
Mirat Shah, Anna Ferguson, Phyllis Dvora Corn, et al.
Journal of the National Cancer Institute
|
December 5, 2003
Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine
Vered Stearns, Michael D Johnson, James M Rae, et al.
Page
of 28